stearoylethanolamide has been researched along with sr141716 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avraham, Y; Berry, EM; Ezra, AF; Grigoriadis, NC; Harfoush, F; Katzhendler, J; Kunkes, E; Listman, C; Merchavia, S; Najajreh, Y; Salameh, S; Vorobeiv, L | 1 |
| Bernardini, D; Colavito, D; D'Arrigo, A; Dalle Carbonare, M; Dam, M; Del Giudice, E; Fabris, M; Leon, A; Stecca, A | 1 |
2 other study(ies) available for stearoylethanolamide and sr141716
| Article | Year |
|---|---|
Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased neuropeptide Y (NPY).
Topics: Amides; Animals; Anti-Obesity Agents; Body Weight; Eating; Ethanolamines; Female; Hypothalamus; Mice; Mice, Inbred C57BL; Mice, Obese; Neuropeptide Y; Nuclear Magnetic Resonance, Biomolecular; Oleic Acids; Pro-Opiomelanocortin; Valine | 2013 |
A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story...
Topics: Amides; Animals; Anti-Inflammatory Agents; Benzoxazines; Body Temperature; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Ear Auricle; Edema; Endocannabinoids; Ethanolamines; Fatty Acids; Female; Inflammation; Mice; Mice, Inbred BALB C; Morpholines; Naphthalenes; Palmitic Acids; Passive Cutaneous Anaphylaxis; Piperidines; Pyrazoles; Rimonabant; Stearic Acids; Time Factors | 2008 |